BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. PBX1, cell-cell adhesion, Arthritis, Embryo, Alcohol, Rosiglitazone, rs4950928)
Bookmark Forward

QuickView for MTAP (gene)


Body Atlas

Most Correlated Tissues

  1. Superior cervical ganglion
  2. Ciliary ganglion
  3. Atrioventricular node
  4. Appendix
  5. Tongue
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Drug resistance
  2. Parvovirus infection
  3. Abscess
  4. B-cell lymphoma
  5. General adaptation syndrome
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. piretanide
  2. Sulfamethizole
  3. Aminopyrine
  4. Nafcillin
  5. N-acetylmuramic acid
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. RHOQ
  2. MUSK
  3. MTAP
  4. APEH
  5. FRY
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. MTAP as an emerging biomarker in thoracic malignancies.
  2. Clinical features of patients with MTAP-deleted bladder cancer.
  3. Deletions of CDKN2A and MTAP Detected by Copy-Number Variation Array Are Associated with Loss of p16…
  4. MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Mode…
  5. Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetic…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma
  2. Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
  3. Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
  4. Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss
  5. A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid Tum…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.